Pharmaron Beijing Co., Ltd. (3759.HK)

HKD 14.46

(7.11%)

Gross Profit Summary of Pharmaron Beijing Co., Ltd.

Pharmaron Beijing Co., Ltd.'s latest annual gross profit in 2023 was 4.12 Billion CNY , up 9.45% from previous year.
Pharmaron Beijing Co., Ltd.'s latest quarterly gross profit in 2024 Q2 was 999.02 Million CNY , up 14.55% from previous quarter.
Pharmaron Beijing Co., Ltd. reported a annual gross profit of 3.76 Billion CNY in annual gross profit 2022, up 40.67% from previous year.
Pharmaron Beijing Co., Ltd. reported a annual gross profit of 2.67 Billion CNY in annual gross profit 2021, up 39.27% from previous year.
Pharmaron Beijing Co., Ltd. reported a quarterly gross profit of 872.14 Million CNY for 2024 Q1, down -16.67% from previous quarter.
Pharmaron Beijing Co., Ltd. reported a quarterly gross profit of 1.11 Billion CNY for 2024 Q3, up 11.63% from previous quarter.

Annual Gross Profit Chart of Pharmaron Beijing Co., Ltd. (2023 - 2014)

Historical Annual Gross Profit of Pharmaron Beijing Co., Ltd. (2023 - 2014)

Year	Gross Profit	Gross Profit Growth
2023	4.12 Billion CNY	9.45%
2022	3.76 Billion CNY	40.67%
2021	2.67 Billion CNY	39.27%
2020	1.92 Billion CNY	44.15%
2019	1.33 Billion CNY	41.25%
2018	944.66 Million CNY	25.79%
2017	751.01 Million CNY	58.44%
2016	474.01 Million CNY	52.71%
2015	310.39 Million CNY	56.49%
2014	198.34 Million CNY	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	999.02 Million CNY	14.55%
2024 Q1	872.14 Million CNY	-16.67%
2024 Q3	1.11 Billion CNY	11.63%
2023 Q1	974.96 Million CNY	-8.65%
2023 FY	4.12 Billion CNY	9.45%
2023 Q4	1.04 Billion CNY	1.73%
2023 Q3	1.02 Billion CNY	-4.22%
2023 Q2	1.07 Billion CNY	10.17%
2022 Q1	695.62 Million CNY	-6.04%
2022 FY	3.76 Billion CNY	40.67%
2022 Q4	1.06 Billion CNY	-1.03%
2022 Q3	1.07 Billion CNY	16.34%
2022 Q2	927 Million CNY	33.26%
2021 FY	2.67 Billion CNY	39.27%
2021 Q4	740.37 Million CNY	-0.7%
2021 Q3	745.56 Million CNY	10.35%
2021 Q1	517.31 Million CNY	-9.24%
2021 Q2	675.65 Million CNY	30.61%
2020 Q2	477.62 Million CNY	48.81%
2020 Q1	320.96 Million CNY	-28.99%
2020 Q3	554.93 Million CNY	16.19%
2020 FY	1.92 Billion CNY	44.15%
2020 Q4	570 Million CNY	2.72%
2019 Q1	251.13 Million CNY	-15.49%
2019 FY	1.33 Billion CNY	41.25%
2019 Q4	452.01 Million CNY	26.41%
2019 Q3	357.57 Million CNY	30.66%
2019 Q2	273.66 Million CNY	8.97%
2018 Q1	195.93 Million CNY	-4.1%
2018 FY	944.66 Million CNY	25.79%
2018 Q4	297.15 Million CNY	17.82%
2018 Q3	252.2 Million CNY	35.54%
2018 Q2	186.07 Million CNY	-5.03%
2017 Q4	204.31 Million CNY	0.0%
2017 FY	751.01 Million CNY	58.44%
2016 FY	474.01 Million CNY	52.71%
2015 FY	310.39 Million CNY	56.49%
2014 FY	198.34 Million CNY	0.0%

Peer Gross Profit Comparison of Pharmaron Beijing Co., Ltd.

Name	Gross Profit	Gross Profit Difference
Uni-Bio Science Group Limited	392.81 Million HKD	-949.973%
CK Life Sciences Int'l., (Holdings) Inc.	947.7 Million HKD	-335.207%